Precigen reports first quarter 2021 financial results

Germantown, md., may 10, 2021 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced first quarter 2021 financial results.
PGEN Ratings Summary
PGEN Quant Ranking